|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
HLA-DR15 haplotypes, including genomic variants of HLA-DRB5, and HLA-DR4 haplotypes affect MS risk.
|
29683085 |
2019 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
BEFREE |
We used an extremes-of-outcome design with 48 benign and 20 malignant MS patients to assess whether or not DNA methylation at HLA-DRB1*1501 and/or HLA-DRB5 also contributes to MS phenotypic heterogeneity.
|
20394989 |
2010 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
Susceptibility is associated with the MHC class II region, especially HLA-DRB5*0101-HLA-DRB1*1501-HLA-DQA1*0102-HLA-DQB1*0602 haplotypes(hereafter DR2), which dominate genetic contribution to MS risk.
|
19380721 |
2009 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
BEFREE |
Thus, HLA-DRB5 attenuates MS severity, a finding consistent with HLA-DRB5's proposed role as a modifier in experimental autoimmune encephalomyelitis.
|
18832704 |
2008 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
LHGDN |
Thus, HLA-DRB5 attenuates MS severity, a finding consistent with HLA-DRB5's proposed role as a modifier in experimental autoimmune encephalomyelitis.
|
18832704 |
2008 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
The frequencies of HLA-DRB3 * 0202 (100%), HLA-DRB1 * 1302 (67%), HLA-DRB3 * 0301 (67%), and HLA-DQB1 * 0301 (67%) were significantly increased in children with multiple sclerosis and the frequencies of HLA-DRB1 * 1501 (40%) and HLA-DRB5 * 0101 (40%) were significantly increased in children with ADEM.
|
15201511 |
2004 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
Among the candidate genes for multiple sclerosis (MS), the strongest influence is conferred by human leucocyte antigen (HLA) class II genes, in particular the DR2, DQ6, Dw2 haplotype (DRB1*1501, DQA1*0102, DQB1*0602).
|
11082515 |
2000 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
These results confirm the proposed positive association of the Dw2 (DRB1*1501 DQA1*0102 DQB1*0602) haplotype with MS in Caucasians in our Turkish population (25 vs. 8, p = 0.003, OR = 3.7).
|
9328791 |
1997 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
In addition, we observed significant transmission distortion and an intrafamilial association of the MS-associated class II haplotype HLA-Dw2.
|
9065561 |
1997 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
In this study, we evaluated the role of the two functional HLA-DR heterodimers, DR2a (DR alpha paired with the beta chain encoded by DRB5*0101) and DR2b (DR alpha paired with the beta chain encoded by DRB1*1501), that are coexpressed in the multiple sclerosis (MS)-associated haplotype HLA-DR15 Dw2, in presenting myelin basic protein (MBP) peptides to MBP-specific T cell lines (TCL).
|
9258250 |
1997 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
BEFREE |
ON differs from both MS and controls regarding HLA-Dw2.
|
8899048 |
1996 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
In fact, analysis of 19 patients homozygous for the MS associated HLA-DR-DQ haplotype HLA-Dw2 showed that this haplotype does not carry the TNF2 allele.
|
8550811 |
1995 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
BEFREE |
Surprisingly, these changes which favour a beneficial, disease-downregulating effect of IL-4 and TGF-beta in MS, were found to be confined to HLA-Dw2-positive patients.
|
9345450 |
1995 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
However, using a sibling pair linkage analysis that restricts haplotype sharing probabilities to defined genetic models, we have not observed linkage of this region to susceptibility in MS. We discuss the basis for association and linkage and conclude that the DR15, DQ6, Dw2 haplotype does represent a susceptibility locus but its contribution to the pathogenesis is small; although it may interact epistatically with other susceptibility genes, this haplotype is not necessary for disease expression.
|
7759607 |
1995 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
This indicates that the Dw2 haplotype, when present in familial MS, may confer a stronger influence in MS susceptibility than generally recognized.
|
8300862 |
1994 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
This observation supports the hypothesis that "normal" genes, common to all carriers of the DR15,DQ6,Dw2 haplotype, confer the increased genetic susceptibility to MS associated with this haplotype.
|
8093808 |
1993 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
The well-established association of DRw15, DQw6, Dw2 alleles and MS susceptibility was confirmed.
|
1361490 |
1992 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
The HLA-DR2/Dw2 haplotype is associated with multiple sclerosis (MS) in the North American Caucasian population.
|
1723064 |
1991 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
BEFREE |
Multiple sclerosis (MS) has, since the 1970s, been known to be associated with the HLA-Dw2 and -DR2 specificities in Caucasian Europeans and North Americans.
|
1926129 |
1991 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
BEFREE |
Conversely to the well-established association of DR2/Dw2 with multiple sclerosis (MS) susceptibility in Caucasoids, several studies have found an association of DR4 in populations from Mediterranean origin.
|
2033119 |
1991 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
BEFREE |
Extensive analysis of restriction fragment length polymorphism using HLA class II and T-cell receptor gene probes has been carried out in an attempt to identify genetic markers more strongly associated with multiple sclerosis than the classically defined antigens DR2, Dw2, and DQw1.
|
2567726 |
1989 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
BEFREE |
The other components of the commonest DR2-containing haplotype of this region, HLA-A3-B7-DR2-Dw2, also tend to be present at higher frequency in MS patients.
|
3509722 |
1987 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
BEFREE |
The frequencies of Properdin factor B allotypes were studied in 54 multiple sclerosis patients and 58 healthy control subjects, and the association of various phenotypes with HLA-Dw1 and Dw2 antigens (found with decreased and increased frequency in MS patients, respectively) was further studied.
|
6558078 |
1983 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
Biomarker |
BEFREE |
In Black American MS patients, the B7 frequency is slightly increased but Dw2 is still significantly associated with MS. For the HLA-DR antigen series DR2 is shown to have a stronger association to MS than A3 and B7.
|
6953617 |
1982 |
|
HLA-DRB5
|
Multiple Sclerosis
|
0.100 |
GeneticVariation |
BEFREE |
The Dw2/DR2 phenotype, known to be associated with increased MS susceptibility, was also associated with a later onset of MS and more rapid progression of disease.
|
7061242 |
1982 |